Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 


Print Friendly Page

Protocol No. A021502

Phase III

Age Group Adult

Scope National

Sponsor Type National

Title A021502: Randomized Trial of FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability (ATOMIC*)

Applicable Disease Sites Colon and Rectum

Drugs Involved 5-fluorouracil; 5-fu (5-fluorouracil); 5fu (5-fluorouracil); Atezolizumab; Eloxatin (oxaliplatin); Eloxatina (oxaliplatin); L-OHP (oxaliplatin); MPDL3280A (Atezolizumab); SR 96669 (oxaliplatin); adrucil (5-fluorouracil); efudex (5-fluorouracil); leucovorin; leukovorin (leucovorin); lv (leucovorin); oxaliplatin; wellcovorin (leucovorin)

Status Open (affiliates only)

Participating Institutions Aspirus UW Cancer Center (formerly Riverview Hospital); Aspirus Wausau Hospital, Aspirus Regional Cancer Center; Langlade Memorial Hospital, Aspirus Regional Cancer Ctr